Charité's Research Centers
In an effort to support high-quality research, these centers offer an attractive research environment to both researchers from Charité and external researchers. With outstanding technological equipment being an integral part of this, these centers offer state-of-the-art technology to a wide network of users. This includes equipment which, due to its complexity and costs, can only be made available in a few select locations. At these centers, researchers collaborate on projects that combine experimental and clinical research, thus promoting the faster translation of basic research findings into clinical application. To the next generation of researchers, these centers provide a base as well as a strong level of support.
Contact: Kerstin Dlab
t: +49 30 450 576 067
Neuroscience Research Center (NWFZ)
The NWFZ, which has close links with the NeuroCure Cluster of Excellence, offers the concentrated expertise of staff working in the field of neuroscience. The center's research groups are actively engaged in research into the fundamental aspects of neuronal processing or, more specifically, the manner in which the brain processes and then stores information. Much of NeuroCure's research contributes to translational research efforts.
Center for Cardiovascular Research (CCR)
With this center, the Faculty promotes research into cardiovascular and metabolic disorders, and provides support for young researchers. The CCR offers the necessary conditions to promote high-quality, cooperative research into heart failure, hypertrophic cardiomyopathy, atherosclerosis, diabetes and obesity. Other research areas being pursued are gender-based differences in cardiovascular disorders and molecular pharmacology.
Research Center ImmunoSciences (RCIS)
The RCIS, an interdisciplinary network of researchers involved in basic and application-based research, concentrates Charité's research efforts in the field of immunology. Aside from focusing on the study of disease etiology, the center is also committed to the development of new treatments for conditions marked by chronic inflammation, such as autoimmune diseases, allergies, cancer, and transplant rejection.
Molecular Cancer Research Center (MKFZ)
The center provides a scientific networking platform for molecular oncology research groups with a focus on experimental research. The concentration of clinical and experimental cancer research efforts promotes the development of a regional network, and brings visible results in the form of new research collaborations. It also ensures support for young researchers, such as that offered through the Berlin School of Integrative Oncology (BSIO), and allows groups of highly-qualified young researchers to be included in collaborative research projects.
Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
At the BCRT, an interdisciplinary translational center based in the field of regenerative medicine, clinicians, researchers and engineers work together to develop therapies that can be used in the treatment of disorders of the immune, musculoskeletal, and cardiovascular systems for which treatment options remain inadequate. The BCRT focuses on studying the body's capacity to heal itself, and on using this knowledge to develop new therapies and diagnostic methods.
Experimental and Clinical Research Center (ECRC)
An institution jointly run by MDC and Charité, the ECRC effectively represents an interface between both partners, a translational platform that enables researchers to develop new diagnostic techniques and treatment approaches. Both the ECRC's research infrastructure, which is based around the needs of patients and study participants, and its close proximity to the MDC, provide ideal conditions for world-class research into the molecular aspects of complex diseases. This combination of factors also provides clinical researchers with the necessary support to guide them along their career paths. In addition, the ECRC's clinical research program provides new impulses for basic research projects conducted at the MDC.
Link to Clinical Journal Club.